Moxifloxacin 1 mg/mL Solution Label Mix-up Recall
Denver Solutions, LLC (doing business as Leiters Health) is recalling Moxifloxacin 1 mg/mL intracameral injection solution because vials labeled as 1 mg/mL may actually contain 5 mg/mL, creating a serious dosing error risk.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this as Class II. The hazard involves a five-fold concentration discrepancy in a prescription drug intended for direct intraocular injection, presenting significant risk of serious patient harm through overdosage. Although no specific illnesses or hospitalizations are mentioned in the source text, the inherent risk of a major dosing error in a potent antibiotic meets the Severe criterion for a Class II recall with serious potential for injury.
Plain-English summary
Denver Solutions, LLC, doing business as Leiters Health, is recalling Moxifloxacin 1 mg/mL intracameral injection solution due to a labeling mix-up. Vials labeled as containing 1 mg/mL of moxifloxacin may actually contain 5 mg/mL of the drug.
The recalled product is Moxifloxacin, 1 mg/mL, 1 mL in 2 mL vials, packaged 10 vials per carton, for prescription-only intracameral injection use. The specific lot affected is Lot #2130958 with an expiration date of March 31, 2022. Approximately 1,440 vials were distributed nationwide within the United States.
Patients who receive the wrong concentration may be exposed to a five-fold overdose of moxifloxacin. Healthcare providers and patients should immediately stop using vials from the recalled lot. Contact the manufacturer at (800) 292-6772 with questions or to report any adverse effects.
The recalled product
- Product
- Moxifloxacin, 1 mg/mL, 1mL in 2mL vial, solution for intracameral injection, 10 vials/carton, Rx only, Leiters 13796 Compark Blvd, Englewood, CO 80112, (800) 292-6772, NDC 71449-096-42
- Manufacturer
- Denver Solutions, LLC DBA Leiters Health
- Hazard
- mis-labeling
- overdosage-risk
- concentration-error
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 2130958
- Expiration Date 03/31/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27